QIN. Promise and pitfalls of quantitative imaging in oncology clinical trials

Quantitative imaging using CT, MRI, and PET modalities will play an increasingly important role in the design of oncology trials addressing molecularly targeted, personalized therapies. The advent of molecularly targeted therapies, exemplified by antiangiogenic drugs, creates new complexities in the...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kurland, Brenda F., Gerstner, Elizabeth R., Mountz, James M., Schwartz, Lawrence H., Ryan, Christopher W., Graham, Michael M., Buatti, John M., Fennessy, Fiona M., Eikman, Edward A., Kumar, Virendra, Forster, Kenneth M., Wahl, Richard L., Lieberman, Frank S.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3466405/
https://ncbi.nlm.nih.gov/pubmed/22898682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mri.2012.06.009
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires